International Clinical Trials Day

Published on: May 20, 2025

SRHU Celebrates International Clinical Trials Day 2025 with Interactive Events and Career-Focused Sessions

The Department of Clinical Research, Himalayan Institute of Medical Sciences (HIMS), SRHU, commemorated International Clinical Trials Day 2025 on May 20 with a series of engaging and informative events. The day honored the pioneering efforts of James Lind and highlighted the crucial role of clinical research in medical advancement.

The celebrations began with a Poster Gallery Visit at the Department of Clinical Research, where students showcased their understanding of emerging trial models. A panel of esteemed judges evaluated the posters, and the best presentation award was given to Dev Saini and Sneha Pandey for their work on “Basket versus Umbrella Trials.” The event saw the participation of 17 enthusiastic students and concluded with a group photo capturing the spirit of academic exploration.

A guest lecture series followed at Sushruta LT-II, featuring insightful talks by Dr. Taruna Sharma and Dr. Nikku Yadav. Over 100 participants attended the session that explored core concepts of clinical research, study design, regulatory norms, and evolving career pathways in the field. The session also emphasized the increasing relevance of translational medicine and concluded with an engaging Q&A round.

In the afternoon, a virtual session organized by ISCR-ICTD introduced attendees to the dynamic field of medical writing. The session discussed document types, required skills, and tips for building a successful career in this specialized domain. The interaction was well-received by participants from various disciplines.

The multi-format celebration successfully deepened understanding of clinical research and inspired students to explore diverse career opportunities in the field, aligning with SRHU’s vision of fostering informed, future-ready healthcare professionals.

International Clinical Trials Day

International Clinical Trials Day-3

International Clinical Trials Day-2

International Clinical Trials Day-1

Admissions Form

Admission Open For 2025

×

International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.